A166

· Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for A166, covering 2023-08-03 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer [Phase 2]